|
J Biol Chem, Vol. 275, Issue 7, 4858-4864, February 18, 2000
Tumor Necrosis Factor- Induces Differentiation of and Bone
Resorption by Osteoclasts*
Yoshiaki
Azuma ,
Keisuke
Kaji§,
Rei
Katogi§,
Sunao
Takeshita§, and
Akira
Kudo§¶
From the Teijin Institute for Biomedical Research,
Teijin Limited, 4-3-2 Asahigaoka, Hino, Tokyo 191-8512, and the
§ Department of Life Science, Tokyo Institute of Technology,
4259 Nagatsuta, Midori-ku, Yokohama 226-8501, Japan
Osteoclast progenitors differentiate into mature
osteoclasts in the presence of receptor activator of NF- B (RANK)
ligand on stromal or osteoblastic cells and monocyte macrophage
colony-stimulating factor (M-CSF). The soluble RANK ligand induces the
same differentiation in vitro without stromal cells. Tumor
necrosis factor- (TNF- ), a potent cytokine involved in the
regulation of osteoclast activity, promotes bone resorption via a
primary effect on osteoblasts; however, it remains unclear whether
TNF- can also directly induce the differentiation of osteoclast
progenitors into mature osteoclasts. This study revealed that TNF-
directly induced the formation of tartrate-resistant acid phosphatase
(TRAP)-positive multinucleated cells (MNCs), which produced resorption
pits on bone in vitro in the presence of M-CSF. The bone
resorption activity of TNF- -induced MNCs was lower than that of
soluble RANK ligand-induced MNCs; however, interleukin-1 stimulated
this activity of TNF- -induced MNCs without an increase in the number
of MNCs. In this case, interleukin-1 did not induce TRAP-positive
MNC formation. The osteoclast progenitors expressed TNF receptors, p55
and p75; and the induction of TRAP-positive MNCs by TNF- was
inhibited completely by an anti-p55 antibody and partially by an
anti-p75 antibody. Our findings presented here are the first to
indicate that TNF- is a crucial differentiation factor for
osteoclasts. Our results suggest that TNF- and M-CSF play an
important role in local osteolysis in chronic inflammatory diseases.
*
This work was supported in part by a grant-in-aid for
scientific research from the Ministry of Education, Science, and
Culture of Japan.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
To whom correspondence should be addressed. Tel. and Fax:
81-45-924-5718; E-mail: akudo@bio.titech.ac.jp.
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
T.-W. Kyung, J.-E. Lee, T. Van Phan, R. Yu, and H.-S. Choi
Osteoclastogenesis by Bone Marrow-Derived Macrophages Is Enhanced in Obese Mice
J. Nutr.,
March 1, 2009;
139(3):
502 - 506.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. D. Yogesha, S. M. Khapli, R. K. Srivastava, L. S. Mangashetti, S. T. Pote, G. C. Mishra, and M. R. Wani
IL-3 Inhibits TNF-{alpha}-Induced Bone Resorption and Prevents Inflammatory Arthritis
J. Immunol.,
January 1, 2009;
182(1):
361 - 370.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Lorenzo, M. Horowitz, and Y. Choi
Osteoimmunology: Interactions of the Bone and Immune System
Endocr. Rev.,
June 1, 2008;
29(4):
403 - 440.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Kitaura, M. Yoshimatsu, Y. Fujimura, T. Eguchi, H. Kohara, A. Yamaguchi, and N. Yoshida
An Anti-c-Fms Antibody Inhibits Orthodontic Tooth Movement
Journal of Dental Research,
April 1, 2008;
87(4):
396 - 400.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. E. Kearns, S. Khosla, and P. J. Kostenuik
Receptor Activator of Nuclear Factor {kappa}B Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease
Endocr. Rev.,
April 1, 2008;
29(2):
155 - 192.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Thalhamer, M. A. McGrath, and M. M. Harnett
MAPKs and their relevance to arthritis and inflammation
Rheumatology,
April 1, 2008;
47(4):
409 - 414.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Ukai, H. Yumoto, F. C. Gibson III, and C. A. Genco
Macrophage-Elicited Osteoclastogenesis in Response to Bacterial Stimulation Requires Toll-Like Receptor 2-Dependent Tumor Necrosis Factor-Alpha Production
Infect. Immun.,
February 1, 2008;
76(2):
812 - 819.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Andrade Jr., T.A. Silva, G.A.B. Silva, A.L. Teixeira, and M.M. Teixeira
The Role of Tumor Necrosis Factor Receptor Type 1 in Orthodontic Tooth Movement
Journal of Dental Research,
November 1, 2007;
86(11):
1089 - 1094.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Ishida, C. Kohda, Y. Yanagawa, H. Miyaoka, and T. Shimamura
Epigallocatechin gallate suppresses expression of receptor activator of NF-{kappa}B ligand (RANKL) in Staphylococcus aureus infection in osteoblast-like NRG cells
J. Med. Microbiol.,
August 1, 2007;
56(8):
1042 - 1046.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C.-H. Tang, T.-L. Hsu, W.-W. Lin, M.-Z. Lai, R.-S. Yang, S.-L. Hsieh, and W.-M. Fu
Attenuation of Bone Mass and Increase of Osteoclast Formation in Decoy Receptor 3 Transgenic Mice
J. Biol. Chem.,
January 26, 2007;
282(4):
2346 - 2354.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. R. Pettit, N. C. Walsh, C. Manning, S. R. Goldring, and E. M. Gravallese
RANKL protein is expressed at the pannus-bone interface at sites of articular bone erosion in rheumatoid arthritis
Rheumatology,
September 1, 2006;
45(9):
1068 - 1076.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. M. Rahman, A. Bhattacharya, and G. Fernandes
Conjugated linoleic acid inhibits osteoclast differentiation of RAW264.7 cells by modulating RANKL signaling
J. Lipid Res.,
August 1, 2006;
47(8):
1739 - 1748.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Torikai, Y. Kageyama, M. Takahashi, M. Suzuki, T. Ichikawa, T. Nagafusa, and A. Nagano
The effect of infliximab on bone metabolism markers in patients with rheumatoid arthritis
Rheumatology,
June 1, 2006;
45(6):
761 - 764.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-T.A. Teng
Protective and Destructive Immunity in the Periodontium: Part 2--T-cell-mediated Immunity in the Periodontium
Journal of Dental Research,
March 1, 2006;
85(3):
209 - 219.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Xu, S. Wang, W. Liu, J. Liu, and X. Feng
A Novel Receptor Activator of NF-{kappa}B (RANK) Cytoplasmic Motif Plays an Essential Role in Osteoclastogenesis by Committing Macrophages to the Osteoclast Lineage
J. Biol. Chem.,
February 24, 2006;
281(8):
4678 - 4690.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Nardelli, L. Zaritskaya, W. McAuliffe, Y. Ni, C. Lincoln, Y. H. Cho, C. E. Birse, W. Halpern, S. Ullrich, and P. A. Moore
Osteostat/Tumor Necrosis Factor Superfamily 18 Inhibits Osteoclastogenesis and Is Selectively Expressed by Vascular Endothelial Cells
Endocrinology,
January 1, 2006;
147(1):
70 - 78.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. K. Frick, K. LaPlante, and D. A. Bushinsky
RANK ligand and TNF-{alpha} mediate acid-induced bone calcium efflux in vitro
Am J Physiol Renal Physiol,
November 1, 2005;
289(5):
F1005 - F1011.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Kim, Y. Kadono, M. Takami, J. Lee, S.-H. Lee, F. Okada, J. H. Kim, T. Kobayashi, P. R. Odgren, H. Nakano, et al.
Osteoclast differentiation independent of the TRANCE-RANK-TRAF6 axis
J. Exp. Med.,
September 6, 2005;
202(5):
589 - 595.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Yang, N. Takahashi, T. Yamashita, N. Sato, M. Takahashi, M. Mogi, T. Uematsu, Y. Kobayashi, Y. Nakamichi, K. Takeda, et al.
Muramyl Dipeptide Enhances Osteoclast Formation Induced by Lipopolysaccharide, IL-1{alpha}, and TNF-{alpha} through Nucleotide-Binding Oligomerization Domain 2-Mediated Signaling in Osteoblasts
J. Immunol.,
August 1, 2005;
175(3):
1956 - 1964.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-T. A. Teng, D. Mahamed, and B. Singh
Gamma Interferon Positively Modulates Actinobacillus actinomycetemcomitans-Specific RANKL+ CD4+ Th-Cell-Mediated Alveolar Bone Destruction In Vivo
Infect. Immun.,
June 1, 2005;
73(6):
3453 - 3461.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. C. Gilbert, J. Rubin, and M. S. Nanes
The p55 TNF receptor mediates TNF inhibition of osteoblast differentiation independently of apoptosis
Am J Physiol Endocrinol Metab,
May 1, 2005;
288(5):
E1011 - E1018.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Kobayashi, T. Mizoguchi, I. Take, S. Kurihara, N. Udagawa, and N. Takahashi
Prostaglandin E2 Enhances Osteoclastic Differentiation of Precursor Cells through Protein Kinase A-dependent Phosphorylation of TAK1
J. Biol. Chem.,
March 25, 2005;
280(12):
11395 - 11403.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. D. Yogesha, S. M. Khapli, and M. R. Wani
Interleukin-3 and Granulocyte-Macrophage Colony-stimulating Factor Inhibits Tumor Necrosis Factor (TNF)-{alpha}-induced Osteoclast Differentiation by Down-regulation of Expression of TNF Receptors 1 and 2
J. Biol. Chem.,
March 25, 2005;
280(12):
11759 - 11769.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Mezyk-Kopec, M. Bzowska, J. Potempa, M. Bzowska, N. Jura, A. Sroka, R. A. Black, and J. Bereta
Inactivation of Membrane Tumor Necrosis Factor Alpha by Gingipains from Porphyromonas gingivalis
Infect. Immun.,
March 1, 2005;
73(3):
1506 - 1514.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Amcheslavsky, W. Zou, and Z. Bar-Shavit
Toll-like Receptor 9 Regulates Tumor Necrosis Factor-{alpha} Expression by Different Mechanisms: IMPLICATIONS FOR OSTEOCLASTOGENESIS
J. Biol. Chem.,
December 24, 2004;
279(52):
54039 - 54045.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Kishimoto, S. Fukumoto, S. Nishihara, H. Mizumura, K. Hirai, and R. Teshima
Gene expression relevant to osteoclastogenesis in the synovium and bone marrow of mature rats with collagen-induced arthritis
Rheumatology,
December 1, 2004;
43(12):
1496 - 1503.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Horiki, T. Imamura, M. Okamoto, M. Hayashi, J. Murai, A. Myoui, T. Ochi, K. Miyazono, H. Yoshikawa, and N. Tsumaki
Smad6/Smurf1 overexpression in cartilage delays chondrocyte hypertrophy and causes dwarfism with osteopenia
J. Cell Biol.,
May 10, 2004;
165(3):
433 - 445.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Saito, N. Ohara, H. Hotokezaka, S. Fukumoto, K. Yuasa, M. Naito, T. Fujiwara, and K. Nakayama
Infection-induced Up-regulation of the Costimulatory Molecule 4-1BB in Osteoblastic Cells and Its Inhibitory Effect on M-CSF/RANKL-induced in Vitro Osteoclastogenesis
J. Biol. Chem.,
April 2, 2004;
279(14):
13555 - 13563.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Hirotani, N. A. Tuohy, J.-T. Woo, P. H. Stern, and N. A. Clipstone
The Calcineurin/Nuclear Factor of Activated T Cells Signaling Pathway Regulates Osteoclastogenesis in RAW264.7 Cells
J. Biol. Chem.,
April 2, 2004;
279(14):
13984 - 13992.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D O' Gradaigh, D Ireland, S Bord, and J E Compston
Joint erosion in rheumatoid arthritis: interactions between tumour necrosis factor {alpha}, interleukin 1, and receptor activator of nuclear factor {kappa}B ligand (RANKL) regulate osteoclasts
Ann Rheum Dis,
April 1, 2004;
63(4):
354 - 359.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Cheng, M. Kinosaki, M. Takami, Y. Choi, H. Zhang, and R. Murali
Disabling of Receptor Activator of Nuclear Factor-{kappa}B (RANK) Receptor Complex by Novel Osteoprotegerin-like Peptidomimetics Restores Bone Loss in Vivo
J. Biol. Chem.,
February 27, 2004;
279(9):
8269 - 8277.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Redlich, B. Gortz, S. Hayer, J. Zwerina, N. Doerr, P. Kostenuik, H. Bergmeister, G. Kollias, G. Steiner, J. S. Smolen, et al.
Repair of Local Bone Erosions and Reversal of Systemic Bone Loss Upon Therapy with Anti-Tumor Necrosis Factor in Combination with Osteoprotegerin or Parathyroid Hormone in Tumor Necrosis Factor-Mediated Arthritis
Am. J. Pathol.,
February 1, 2004;
164(2):
543 - 555.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. O'Gradaigh and J. E. Compston
T-cell involvement in osteoclast biology: implications for rheumatoid bone erosion
Rheumatology,
February 1, 2004;
43(2):
122 - 130.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Li, N. Udagawa, M. Takami, N. Sato, Y. Kobayashi, and N. Takahashi
p38 Mitogen-Activated Protein Kinase Is Crucially Involved in Osteoclast Differentiation But Not in Cytokine Production, Phagocytosis, or Dendritic Cell Differentiation of Bone Marrow Macrophages
Endocrinology,
November 1, 2003;
144(11):
4999 - 5005.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. O'Gradaigh, S. Bord, D. Ireland, and J. E. Compston
Osteoclastic bone resorption in rheumatoid arthritis and the acute-phase response
Rheumatology,
November 1, 2003;
42(11):
1429 - 1430.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. C. Polek, M. Talpaz, B. G. Darnay, and T. Spivak-Kroizman
TWEAK Mediates Signal Transduction and Differentiation of RAW264.7 Cells in the Absence of Fn14/TweakR: EVIDENCE FOR A SECOND TWEAK RECEPTOR
J. Biol. Chem.,
August 22, 2003;
278(34):
32317 - 32323.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-T. A. Teng
THE ROLE OF ACQUIRED IMMUNITY AND PERIODONTAL DISEASE PROGRESSION
Critical Reviews in Oral Biology & Medicine,
July 1, 2003;
14(4):
237 - 252.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M. Khapli, L. S. Mangashetti, S. D. Yogesha, and M. R. Wani
IL-3 Acts Directly on Osteoclast Precursors and Irreversibly Inhibits Receptor Activator of NF-{kappa}B Ligand-Induced Osteoclast Differentiation by Diverting the Cells to Macrophage Lineage
J. Immunol.,
July 1, 2003;
171(1):
142 - 151.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H Tsuboi, Y Matsui, K Hayashida, S Yamane, M Maeda-Tanimura, A Nampei, J Hashimoto, R Suzuki, H Yoshikawa, and T Ochi
Tartrate resistant acid phosphatase (TRAP) positive cells in rheumatoid synovium may induce the destruction of articular cartilage
Ann Rheum Dis,
March 1, 2003;
62(3):
196 - 203.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. P. Armstrong, M. E. Tometsko, M. Glaccum, C. L. Sutherland, D. Cosman, and W. C. Dougall
A RANK/TRAF6-dependent Signal Transduction Pathway Is Essential for Osteoclast Cytoskeletal Organization and Resorptive Function
J. Biol. Chem.,
November 8, 2002;
277(46):
44347 - 44356.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D H. Jones, Y-Y Kong, and J M Penninger
Role of RANKL and RANK in bone loss and arthritis
Ann Rheum Dis,
November 1, 2002;
61(90002):
ii32 - 39.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. A. Ragab, J. L. Nalepka, Y. Bi, and E. M. Greenfield
Cytokines synergistically induce osteoclast differentiation: support by immortalized or normal calvarial cells
Am J Physiol Cell Physiol,
September 1, 2002;
283(3):
C679 - C687.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Li, N. Udagawa, K. Itoh, K. Suda, Y. Murase, T. Nishihara, T. Suda, and N. Takahashi
p38 MAPK-Mediated Signals Are Required for Inducing Osteoclast Differentiation But Not for Osteoclast Function
Endocrinology,
August 1, 2002;
143(8):
3105 - 3113.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Takami, N. Kim, J. Rho, and Y. Choi
Stimulation by Toll-Like Receptors Inhibits Osteoclast Differentiation
J. Immunol.,
August 1, 2002;
169(3):
1516 - 1523.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Ji, A. Pettit, K. Ohmura, A. Ortiz-Lopez, V. Duchatelle, C. Degott, E. Gravallese, D. Mathis, and C. Benoist
Critical Roles for Interleukin 1 and Tumor Necrosis Factor {alpha} in Antibody-induced Arthritis
J. Exp. Med.,
July 1, 2002;
196(1):
77 - 85.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Tintut, F. Parhami, A. Tsingotjidou, S. Tetradis, M. Territo, and L. L. Demer
8-Isoprostaglandin E2 Enhances Receptor-activated NFkappa B Ligand (RANKL)-dependent Osteoclastic Potential of Marrow Hematopoietic Precursors via the cAMP Pathway
J. Biol. Chem.,
April 12, 2002;
277(16):
14221 - 14226.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S.D. Neale, E. Schulze, R. Smith, and N.A. Athanasou
The influence of serum cytokines and growth factors on osteoclast formation in Paget's disease
QJM,
April 1, 2002;
95(4):
233 - 240.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H Bull, P G Murray, D Thomas, A M Fraser, and P N Nelson
Acid phosphatases
Mol. Pathol.,
April 1, 2002;
55(2):
65 - 72.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Fuller, C. Murphy, B. Kirstein, S. W. Fox, and T. J. Chambers
TNF{alpha} Potently Activates Osteoclasts, through a Direct Action Independent of and Strongly Synergistic with RANKL
Endocrinology,
March 1, 2002;
143(3):
1108 - 1118.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Wei, M. W.-H. Wang, S. L. Teitelbaum, and F. P. Ross
Interleukin-4 Reversibly Inhibits Osteoclastogenesis via Inhibition of NF-kappa B and Mitogen-activated Protein Kinase Signaling
J. Biol. Chem.,
February 15, 2002;
277(8):
6622 - 6630.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Pfeilschifter, R. Koditz, M. Pfohl, and H. Schatz
Changes in Proinflammatory Cytokine Activity after Menopause
Endocr. Rev.,
February 1, 2002;
23(1):
90 - 119.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. C. Mansky, S. Sulzbacher, G. Purdom, L. Nelsen, D. A. Hume, M. Rehli, and M. C. Ostrowski
The microphthalmia transcription factor and the related helix-loop-helix zipper factors TFE-3 and TFE-C collaborate to activate the tartrate-resistant acid phosphatase promoter
J. Leukoc. Biol.,
February 1, 2002;
71(2):
304 - 310.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Roggia, Y. Gao, S. Cenci, M. N. Weitzmann, G. Toraldo, G. Isaia, and R. Pacifici
Up-regulation of TNF-producing T cells in the bone marrow: A key mechanism by which estrogen deficiency induces bone loss in vivo
PNAS,
November 20, 2001;
98(24):
13960 - 13965.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Miyamoto, O. Ohneda, F. Arai, K. Iwamoto, S. Okada, K. Takagi, D. M. Anderson, and T. Suda
Bifurcation of osteoclasts and dendritic cells from common progenitors
Blood,
October 15, 2001;
98(8):
2544 - 2554.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. A. Watkins, Y. Li, H. E. Lippman, and M. F. Seifert
Omega-3 Polyunsaturated Fatty Acids and Skeletal Health
Experimental Biology and Medicine,
June 1, 2001;
226(6):
485 - 497.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Wei, S. L. Teitelbaum, M. W.-H. Wang, and F. P. Ross
Receptor Activator of Nuclear Factor-{{kappa}}B Ligand Activates Nuclear Factor-{{kappa}}B in Osteoclast Precursors
Endocrinology,
March 1, 2001;
142(3):
1290 - 1295.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Kaji, S. Takeshita, K. Miyake, T. Takai, and A. Kudo
Functional Association of CD9 with the Fc{{gamma}} Receptors in Macrophages
J. Immunol.,
March 1, 2001;
166(5):
3256 - 3265.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. E. Lee, W. J. Chung, H. B. Kwak, C.-H. Chung, K. Kwack, Z. H. Lee, and H.-H. Kim
Tumor Necrosis Factor-alpha Supports the Survival of Osteoclasts through the Activation of Akt and ERK
J. Biol. Chem.,
December 21, 2001;
276(52):
49343 - 49349.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Chikazu, Y. Hakeda, N. Ogata, K. Nemoto, A. Itabashi, T. Takato, M. Kumegawa, K. Nakamura, and H. Kawaguchi
Fibroblast Growth Factor (FGF)-2 Directly Stimulates Mature Osteoclast Function through Activation of FGF Receptor 1 and p42/p44 MAP Kinase
J. Biol. Chem.,
September 29, 2000;
275(40):
31444 - 31450.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|